Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?

INTRODUCTION: To adequately ascertain drug safety and efficacy, drug trials need to include participants from all groups likely to receive the medication following approval. Pregnant women, however, are mostly excluded from trials, and women participating are often required to use highly effective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairlie, Lee, Waitt, Catriona, Lockman, Shahin, Moorhouse, Michelle, Abrams, Elaine J., Clayden, Polly, Boffito, Marta, Khoo, Saye, Rees, Helen, Cournil, Amandine, Venter, Willem Francois, Serenata, Celicia, Chersich, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747006/
https://www.ncbi.nlm.nih.gov/pubmed/31529598
http://dx.doi.org/10.1002/jia2.25372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747006/
https://www.ncbi.nlm.nih.gov/pubmed/31529598
http://dx.doi.org/10.1002/jia2.25372

Ejemplares similares